181 related articles for article (PubMed ID: 30373600)
1. microRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer.
Liu X; Cai H; Sheng W; Huang H; Long Z; Wang Y
BMC Cancer; 2018 Oct; 18(1):1048. PubMed ID: 30373600
[TBL] [Abstract][Full Text] [Related]
2. Identification and functional characterization of microRNAs reveal a potential role in gastric cancer progression.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Clin Transl Oncol; 2017 Feb; 19(2):162-172. PubMed ID: 27173517
[TBL] [Abstract][Full Text] [Related]
3. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma.
Wang J; Zhang H; Zhou X; Wang T; Zhang J; Zhu W; Zhu H; Cheng W
Cancer Biomark; 2018; 23(2):193-203. PubMed ID: 30198863
[TBL] [Abstract][Full Text] [Related]
4. microRNA analysis of gastric cancer patients from Saudi Arabian population.
Bibi F; Naseer MI; Alvi SA; Yasir M; Jiman-Fatani AA; Sawan A; Abuzenadah AM; Al-Qahtani MH; Azhar EI
BMC Genomics; 2016 Oct; 17(Suppl 9):751. PubMed ID: 27766962
[TBL] [Abstract][Full Text] [Related]
5. Co-expression profiling of plasma miRNAs and long noncoding RNAs in gastric cancer patients.
Ghaedi H; Mozaffari MAN; Salehi Z; Ghasemi H; Zadian SS; Alipoor S; Hadianpour S; Alipoor B
Gene; 2019 Mar; 687():135-142. PubMed ID: 30447342
[TBL] [Abstract][Full Text] [Related]
6. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus.
Slotta-Huspenina J; Drecoll E; Feith M; Habermehl D; Combs S; Weichert W; Bettstetter M; Becker K; Langer R
J Transl Med; 2018 Apr; 16(1):109. PubMed ID: 29695253
[TBL] [Abstract][Full Text] [Related]
8. Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network.
Zhu Y; Peng Q; Lin Y; Zou L; Shen P; Chen F; Min M; Shen L; Chen J; Shen B
Oncotarget; 2017 Jan; 8(2):2233-2248. PubMed ID: 27903980
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs 142-3p, miR-155 and miR-203 Are Deregulated in Gastric MALT Lymphomas Compared to Chronic Gastritis.
Fernández C; Bellosillo B; Ferraro M; Seoane A; Sánchez-González B; Pairet S; Pons A; Barranco L; Vela MC; Gimeno E; Colomo L; Besses C; Navarro A; Salar A
Cancer Genomics Proteomics; 2017 Jan; 14(1):75-82. PubMed ID: 28031239
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma.
Yang X; Zhang Z; Zhang L; Zhou L
Sci Rep; 2020 Mar; 10(1):4672. PubMed ID: 32170105
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of candidate microRNAs in gastric cancer: A validation study.
Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P
Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528
[TBL] [Abstract][Full Text] [Related]
13. Serum miR-515-3p, a potential new RNA biomarker, is involved in gastric carcinoma.
Han X; Li X; Zhao H; Zhou D; Sun B; Liu A; Zhang J; Cui Z; Ma X; Yuan L
J Cell Biochem; 2019 Sep; 120(9):15834-15843. PubMed ID: 31081157
[TBL] [Abstract][Full Text] [Related]
14. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients.
Lopes-Ramos CM; Habr-Gama A; Quevedo Bde S; Felício NM; Bettoni F; Koyama FC; Asprino PF; Galante PA; Gama-Rodrigues J; Camargo AA; Perez RO; Parmigiani RB
BMC Med Genomics; 2014 Dec; 7():68. PubMed ID: 25496125
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis.
Li H; Xie S; Liu M; Chen Z; Liu X; Wang L; Li D; Zhou Y
Int J Oncol; 2014 Jul; 45(1):197-208. PubMed ID: 24805774
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues.
Guo J; Miao Y; Xiao B; Huan R; Jiang Z; Meng D; Wang Y
J Gastroenterol Hepatol; 2009 Apr; 24(4):652-7. PubMed ID: 19175831
[TBL] [Abstract][Full Text] [Related]
18. A Three-MicroRNA Signature as a Potential Biomarker for the Early Detection of Oral Cancer.
Chang YA; Weng SL; Yang SF; Chou CH; Huang WC; Tu SJ; Chang TH; Huang CN; Jong YJ; Huang HD
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518940
[TBL] [Abstract][Full Text] [Related]
19. Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
Zhang J; Song Y; Zhang C; Zhi X; Fu H; Ma Y; Chen Y; Pan F; Wang K; Ni J; Jin W; He X; Su H; Cui D
Theranostics; 2015; 5(7):733-45. PubMed ID: 25897338
[TBL] [Abstract][Full Text] [Related]
20. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
